Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
|
|
Intersect ENT, Inc. (XENT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/12/2022 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/12/2022 |
RW WD
| Form RW WD - Withdrawal of Registration Withdrawal Request: |
| 05/23/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 05/19/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/18/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/16/2022 |
4
| Hattangadi Neil A (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 13,993 options to buy
@ $21.44, valued at
$300k
|
|
| 05/16/2022 |
4
| MEIER RICHARD A (EVP & CFO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 57,230 shares
@ $28.25, valued at
$1.6M
Unknown transaction of 65,759 shares
@ $28.25, valued at
$1.9M
Unknown transaction of 40,607 shares
@ $28.25, valued at
$1.1M
Unknown transaction of 34,000 options to buy
@ $23.07, valued at
$784.4k
Unknown transaction of 74,852 options to buy
@ $21.6, valued at
$1.6M
|
|
| 05/16/2022 |
4
| Fernandez Reyna M (Chief Human Resource Officer) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 28,165 shares
@ $28.25, valued at
$795.7k
Unknown transaction of 3,411 shares
@ $28.25, valued at
$96.4k
Unknown transaction of 29,993 options to buy
@ $19.89, valued at
$596.6k
|
|
| 05/16/2022 |
4
| BRODERICK PATRICK A (EVP, GC & Corporate Secretary) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 41,999 shares
@ $28.25, valued at
$1.2M
Unknown transaction of 5,117 shares
@ $28.25, valued at
$144.6k
Unknown transaction of 44,989 options to buy
@ $19.89, valued at
$894.8k
|
|
| 05/16/2022 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 3,239 shares
@ $28.25, valued at
$91.5k
Unknown transaction of 5,011 shares
@ $28.25, valued at
$141.6k
Unknown transaction of 29,262 shares
@ $28.25, valued at
$826.7k
Unknown transaction of 120,064 options to buy
@ $25.1, valued at
$3M
Unknown transaction of 3,390 options to buy
@ $21, valued at
$71.2k
Unknown transaction of 82,387 options to buy
@ $17.01, valued at
$1.4M
Unknown transaction of 5,734 options to buy
@ $16.5, valued at
$94.6k
Unknown transaction of 12,500 options to buy
@ $13.79, valued at
$172.4k
Unknown transaction of 9,666 options to buy
@ $11.84, valued at
$114.4k
Unknown transaction of 3,473 options to buy
@ $42.05, valued at
$146k
Unknown transaction of 6,035 options to buy
@ $26.05, valued at
$157.2k
|
|
| 05/16/2022 |
4
| Sandoval Elisabeth (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 15,896 options to buy
@ $20.98, valued at
$333.5k
|
|
| 05/16/2022 |
4
| West Thomas A. (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 39,700 shares
@ $28.25, valued at
$1.1M
Unknown transaction of 104,456 shares
@ $28.25, valued at
$3M
Unknown transaction of 207,592 shares
@ $28.25, valued at
$5.9M
Unknown transaction of 78,700 options to buy
@ $26.18, valued at
$2.1M
Unknown transaction of 118,461 options to buy
@ $23.07, valued at
$2.7M
Unknown transaction of 97,960 options to buy
@ $20.44, valued at
$2M
Unknown transaction of 427,147 options to buy
@ $20.44, valued at
$8.7M
|
|
| 05/16/2022 |
4
| Kline Teresa L. (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 8,837 shares
@ $28.25, valued at
$249.6k
Unknown transaction of 3,239 shares
@ $28.25, valued at
$91.5k
Unknown transaction of 3,220 options to buy
@ $28.58, valued at
$92k
Unknown transaction of 3,355 options to buy
@ $24.45, valued at
$82k
Unknown transaction of 5,172 options to buy
@ $23.02, valued at
$119.1k
Unknown transaction of 3,390 options to buy
@ $21, valued at
$71.2k
Unknown transaction of 5,734 options to buy
@ $16.5, valued at
$94.6k
Unknown transaction of 9,666 options to buy
@ $11.84, valued at
$114.4k
Unknown transaction of 3,473 options to buy
@ $42.05, valued at
$146k
Unknown transaction of 2,797 options to buy
@ $33.95, valued at
$95k
Unknown transaction of 13,787 options to buy
@ $27.55, valued at
$379.8k
|
|
| 05/16/2022 |
4
| Lucchese Cynthia L (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 16,383 shares
@ $28.25, valued at
$462.8k
Unknown transaction of 3,239 shares
@ $28.25, valued at
$91.5k
Unknown transaction of 3,220 options to buy
@ $28.58, valued at
$92k
Unknown transaction of 5,172 options to buy
@ $23.02, valued at
$119.1k
Unknown transaction of 3,390 options to buy
@ $21, valued at
$71.2k
Unknown transaction of 5,734 options to buy
@ $16.5, valued at
$94.6k
Unknown transaction of 12,500 options to buy
@ $13.79, valued at
$172.4k
Unknown transaction of 9,666 options to buy
@ $11.84, valued at
$114.4k
Unknown transaction of 25,000 options to buy
@ $11.12, valued at
$278k
Unknown transaction of 3,473 options to buy
@ $42.05, valued at
$146k
Unknown transaction of 2,797 options to buy
@ $33.95, valued at
$95k
|
|
| 05/16/2022 |
4
| Mead Dana G Jr. (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 20,890 shares
@ $28.25, valued at
$590.1k
Unknown transaction of 3,239 shares
@ $28.25, valued at
$91.5k
Unknown transaction of 5,172 options to buy
@ $23.02, valued at
$119.1k
Unknown transaction of 12,500 options to buy
@ $16.53, valued at
$206.6k
Unknown transaction of 5,734 options to buy
@ $16.5, valued at
$94.6k
Unknown transaction of 12,500 options to buy
@ $13.79, valued at
$172.4k
Unknown transaction of 9,666 options to buy
@ $11.84, valued at
$114.4k
Unknown transaction of 3,473 options to buy
@ $42.05, valued at
$146k
Unknown transaction of 12,500 options to buy
@ $27.45, valued at
$343.1k
Unknown transaction of 6,035 options to buy
@ $26.05, valued at
$157.2k
|
|
| 05/13/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/13/2022 |
RW
| Form RW - Registration Withdrawal Request: |
| 05/13/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/13/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 05/09/2022 |
8-K
| Other Events Interactive Data |
| 05/04/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/29/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 04/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
|
|
|